BVI Medical

BVI Medical BVI® is refocusing the future of vision. We trust and empower our associates to make decisions and solve problems because collaboration drives us.

As one of the fastest-growing, diversified surgical ophthalmic businesses in the world, our purpose-built portfolio of trusted brands includes: Beaver® (Knives and Blades), Visitec® (Cannulas), Malosa® (Single-Use Instruments), Vitreq® (Vitreoretinal Surgical Products) and PhysIOL® (Premium IOLs), and spans more than 90 countries. We’ve set our sights on touching the lives of millions of patients affected by conditions such as cataracts, refractive error, glaucoma, retinal disease, and dry eye. Unburdened by legacy or bureaucracy, we have developed our strategy around a simple concept – taking pride in delivering innovative solutions for our physicians and patients, based on their needs. Valuing agility, simplicity, and transparency, we stay committed to listening to our customers, delivering for our patients, and keeping the future in focus.

12/24/2025

The BVI community is grateful for the people, partnerships, and progress that shaped our year. Thank you for being part of our journey during 2025, here’s to continued innovation and a bright year ahead. 💡

Wishing you and your loved ones happy holidays and a strong start to 2026! 🙌

Can the use of ® diffractive trifocal IOLs provide good outcomes in eyes with previous LCRS or RK?👉 Swipe to see the ke...
12/23/2025

Can the use of ® diffractive trifocal IOLs provide good outcomes in eyes with previous LCRS or RK?
👉 Swipe to see the key findings from this new peer-reviewed study, including visual acuity at different distances as well as the conclusion of the study.

Congratulations to Dr Jérôme C. Vryghem (Brussels Eye Doctors, Belgium) and co-authors on the recent publication of their paper: “Clinical Outcomes Using a Trifocal Intraocular Lens in Eyes After Previous Laser Corneal Refractive Surgery or Radial Keratotomy: 1-Year of Follow-Up.”

Results at 1 year:
• LASIK/PRK group: 92.16% of eyes were within ±0.50D and 99.02% within ±1.00D.
• RK group: 81.82% of eyes were within ±0.50D and 100% within ±1.00D.

Read the full open-access paper here: https://loom.ly/PG6EMEk

Not all products or offerings are approved or available in every market.

Retention doesn’t start at year one, it starts on day one.In a recent HR.com article, our CPO, Andrew Dawson, shares w...
12/18/2025

Retention doesn’t start at year one, it starts on day one.

In a recent HR.com article, our CPO, Andrew Dawson, shares why the first 90 days are the strongest predictor of long-term engagement, and how trust, belonging, and career clarity shape whether people stay and grow.

https://loom.ly/k2aQXZs

Would you like to see real-world data on the performance of ISOPURE SERENITY premium monofocal hydrophobic IOL?Swipe thr...
12/17/2025

Would you like to see real-world data on the performance of ISOPURE SERENITY premium monofocal hydrophobic IOL?
Swipe through to see Week 6 post-op outcomes from one of Mr David Shahnazaryan’s early patients, featured in today’s edition of 'SERENITY Early Outcomes'.
Do you have your own SERENITY data to share? We would love to hear from you! Contact your local BVI sales representative today.

Not all products or offerings are approved or available in every market.

12/15/2025

Behind every one of our milestones is our extraordinary BVI community—sharing knowledge, supporting teams, and taking pride in everything we do.

Ray Farmer, Sr. Surgical Equipment Manager, reflects on what makes BVI special: expertise, dedication, and a passion for helping others.

👉 Explore our open roles and join the team: https://loom.ly/UGR6O24

What misconceptions still surround premium trifocal IOLs and what does the evidence actually show? 💡In the final part of...
12/13/2025

What misconceptions still surround premium trifocal IOLs and what does the evidence actually show? 💡

In the final part of our 3-episode series, Professor Damien Gatinel addresses a common myth about trifocal intraocular lenses and explains how today’s advanced optics differ significantly from early multifocal designs.

Professor Gatinel also shares clear language and strategies to help surgeons navigate patient concerns and clinician conversations, bringing evidence-based clarity to premium IOL discussions and supporting confidence in guiding patients toward a full range of vision.

🎧 Episode 3 is live! https://loom.ly/svKMeKw

How are premium trifocal IOLs performing in real-world surgical practice and patient experience? 💡 In the second part of...
12/11/2025

How are premium trifocal IOLs performing in real-world surgical practice and patient experience? 💡

In the second part of our 3-episode series, Professor Damien Gatinel reviews surgical outcomes, refractive results, and visual quality across all distances offering a clear view into the performance of today’s premium trifocal platforms.

Gatinel also shares patient-reported insights, highlighting how careful biometry, astigmatism management, and expectation setting can enhance satisfaction and functional independence for well-selected candidates, perspective you can bring directly into your practice.

🎧 Episode 2 is live! https://loom.ly/l6Rc60Q

Innovation starts with listening 💡🎧 BVI’s SVP of R&D, Mikhail Boukhny, shares how the most meaningful breakthroughs in o...
12/10/2025

Innovation starts with listening 💡🎧

BVI’s SVP of R&D, Mikhail Boukhny, shares how the most meaningful breakthroughs in ophthalmology come from understanding the real needs of surgeons, staff, and patients. From simplifying OR workflows to designing future-ready platforms, Mikhail explores how human insight shapes the next generation of ophthalmic solutions.

Read the full article in Medical Product Outsourcing: https://loom.ly/Euv0cME

Innovation or proven performance? With the platform, you don’t have to choose!Swipe to see the peer-reviewed results s...
12/10/2025

Innovation or proven performance? With the platform, you don’t have to choose!
Swipe to see the peer-reviewed results showing refractive accuracy — and check out the Distinct by Design section on page 3 to learn about the innovation behind our unique open double C-loop haptic platform:
https://loom.ly/T647hOI
Available with all BVI optic technologies.
Not all products or offerings are approved or available in every market.

. We’re grateful to have contributed once again to one of the leading congresses in medical and surgical retina — a key...
12/09/2025

. We’re grateful to have contributed once again to one of the leading congresses in medical and surgical retina — a key event where clinicians, researchers, and industry experts come together to explore the latest advancements in vitreoretinal surgery.

We were thrilled to sponsor an exclusive educational session showcasing the clinical potential of endoscopy and Endoscopic Cyclophotocoagulation (ECP) in VR surgery, led by two outstanding surgeons: Dr. Sébastien Guigou and Dr. Loïc Bazin.

It was equally inspiring to join EYENOVATE for a conversation on current and future trends in surgical innovation, and to highlight Virtuoso® — our high-performance surgical platform enabling market-leading applications across cataract, vitrectomy, and combined procedures.

A special thank you to Dr. Tommaso Rossi for his insightful contribution to Saturday’s SURGICAL INNOVATIONS session, and to Dr. Robert Henderson presenting on endoscopy applications for posterior segment surgery.
And, a heartfelt thanks to everyone who visited our booth. Your energy and engagement motivate us every day.
Together, let’s keep the future in focus!

At BVI, we encourage a paperless environment by removing paper IFU in our intraocular lenses packaging.Learn more about ...
12/09/2025

At BVI, we encourage a paperless environment by removing paper IFU in our intraocular lenses packaging.
Learn more about our commitment to sustainability and ESG initiatives here: https://www.bvimedical.com/esg

What innovations and insights are shaping today’s premium IOL landscape? 💡 You won’t want to miss Professor Damien Gatin...
12/09/2025

What innovations and insights are shaping today’s premium IOL landscape? 💡

You won’t want to miss Professor Damien Gatinel in the first episode of our three-part series, where he walks us through the evolution of the trifocal intraocular lens and its pathway to the US market.

Built on decades of optical innovation and clinical insight, today’s trifocal platforms deliver the continuity of vision surgeons expect across all distances. Professor Gatinel traces the progression from early multifocal designs to modern trifocals, offering perspectives that can support premium IOL decision-making and strengthen patient conversations.

🎧 Episode is live! https://loom.ly/ZofKHdM

Address

303 Wyman Street
Waltham, MA
MA02451

Telephone

+18669068080

Website

Alerts

Be the first to know and let us send you an email when BVI Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Specialized in the research, development and manufacture of innovative optical solutions for cataract surgery, our products are supplied to ophthalmic surgeons in over 70 countries, through a worldwide network. Our expertise covers all steps of development and manufacture of intraocular lenses. It extends from polymer chemistry through to sterilization processes, including modelling and risk-control associated with implantable materials.